Top Links You Must Click On
From the Wires
Albany College of Pharmacy and Health Sciences Faculty Member Receives $353,400 Grant for Leukemia Research
By: Marketwired .
Jan. 28, 2013 06:12 AM
COLCHESTER, VT -- (Marketwire) -- 01/28/13 -- Karen Glass, Ph.D., assistant professor in the Department of Pharmaceutical Sciences at Albany College of Pharmacy and Health Sciences' Vermont Campus, has been awarded a three-year research grant totaling $353,400 from the National Institutes of Health (NIH). Dr. Glass will seek to identify new ways to prevent and treat a type of leukemia called Acute Myeloid Leukemia (AML).
What is AML?
Genetic mutations, however, can cause these cellular processes to break down. In AML, there is a mutation known as chromosomal translocation, where a chromosome breaks and incorrectly re-fuses to another chromosome.
Factors including environmental toxins, benzene exposure, and drugs used for chemotherapy may cause AML-related translocations, but in many cases, scientists are still unclear on the specific triggers. There is also much to be learned as to which specific combinations of gene mutations lead to AML and other forms of disease.
With support from students at the College, Dr. Glass will be studying the factors that regulate gene activity in AML and explore if these factors can be manipulated to treat or possibly prevent disease.
Quote from Dr. Glass
The project described above is supported by the National Institute of General Medical Sciences of the National Institutes of Health under Award Number R15GM104865. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
About Albany College of Pharmacy and Health Sciences
Image Available: http://www2.marketwire.com/mw/frame_mw?attachid=2211826
Enterprise Open Source Magazine Latest Stories . . .
Subscribe to the World's Most Powerful Newsletters
Subscribe to Our Rss Feeds & Get Your SYS-CON News Live!
SYS-CON Featured Whitepapers
Most Read This Week